STA
OGN icon

Summit Trail Advisors’s Organon & Co OGN Stock Holding History

Summit Trail Advisors’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$477K Sell
35,194
-300
-0.8% -$3.59K 0.01% 1233
2026
Q1 		$213K Sell
35,494
-19,089
-35% -$144K ﹤0.01% 1367
2025
Q4 		$391K Buy
54,583
+31,944
+141% +$252K 0.01% 1148
2025
Q3 		$242K Buy
22,639
+4,021
+22% +$39.5K ﹤0.01% 1251
2025
Q2 		$180K Buy
18,618
+6,193
+50% +$63.9K ﹤0.01% 1069
2025
Q1 		$185K Buy
+12,425
New +$191K 0.01% 383

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Summit Trail Advisors's OGN Position: Q2 2026 in Review

Summit Trail Advisors reduced its Organon & Co (OGN) stake by 0.85% in Q2 2026, selling an estimated $3.59K and leaving 35,194 shares worth $477K. The position accounts for 0.01% of the portfolio, ranked #1233.

Summit Trail Advisors first reported a position in OGN in Q1 2025 and has held it in 6 quarters since. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Summit Trail Advisors held 35,194 shares of Organon & Co worth $477K as of Q2 2026.
  • Summit Trail Advisors sold 300 Organon & Co shares in Q2 2026, an estimated $3.59K.
  • Organon & Co made up 0.01% of Summit Trail Advisors's portfolio in Q2 2026, its #1233 holding.
  • Summit Trail Advisors first reported a position in Organon & Co in Q1 2025 and has held it in 6 quarters since.
  • 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.